NEW YORK, Aug. 17 (GenomeWeb News) - Odyssey Thera will license its protein-fragment complementation assays to the National Institutes of Health to aid in the federal body's Molecular Libraries Roadmap Initiative, Odyssey said today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.